D
Denali Therapeutics Inc. DNLI
$15.49 $0.261.71% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -- -- -- 0.00 1.27M
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- 0.00 1.27M
Cost of Revenue 228.35M 227.53M 228.73M 244.65M 236.15M
Gross Profit -228.35M -227.53M -228.73M -244.65M -234.88M
SG&A Expenses 116.63M 109.56M 105.44M 100.15M 100.52M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 533.58M 515.21M 501.88M 512.50M 504.38M
Operating Income -533.58M -515.21M -501.88M -512.50M -503.11M
Income Before Tax -478.97M -453.87M -422.71M -427.46M -419.62M
Income Tax Expenses 68.00K 68.00K 68.00K 30.00K 30.00K
Earnings from Continuing Operations -479.03 -453.94 -422.77 -427.49 -419.65
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -479.03M -453.94M -422.77M -427.49M -419.65M
EBIT -533.58M -515.21M -501.88M -512.50M -503.11M
EBITDA -523.87M -508.40M -495.23M -503.95M -494.61M
EPS Basic -2.81 -2.67 -2.58 -2.76 -2.85
Normalized Basic EPS -1.79 -1.71 -1.74 -1.92 -1.98
EPS Diluted -2.81 -2.67 -2.58 -2.76 -2.85
Normalized Diluted EPS -1.79 -1.71 -1.74 -1.92 -1.98
Average Basic Shares Outstanding 682.21M 679.60M 657.78M 625.94M 594.13M
Average Diluted Shares Outstanding 682.21M 679.60M 657.78M 625.94M 594.13M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --